LWM
GCVRZ

Liberty Wealth Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Liberty Wealth Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed – – 1034
2019
Q4 		$0 Hold
100
– – ﹤0.01% 987
2019
Q3 		$0 Hold
100
– – ﹤0.01% 1040
2019
Q2 		$0 Hold
100
– – ﹤0.01% 972
2019
Q1 		$0 Buy
+100
New +$47 ﹤0.01% 897

Liberty Wealth Management's GCVRZ Position: Q1 2020 in Review

Liberty Wealth Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 100 shares.

Liberty Wealth Management first reported a position in GCVRZ in Q1 2019 and held it in 4 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Liberty Wealth Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Liberty Wealth Management sold 100 Sanofi Contingent Value Rights shares in Q1 2020.
  • Liberty Wealth Management first reported a position in Sanofi Contingent Value Rights in Q1 2019 and held it in 4 quarters.
  • Liberty Wealth Management's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Liberty Wealth Management's 13F filing for Q1 2020, filed 27 Apr 2020.